1 Min Read
Feb 11 (Reuters) - Sanofi SA : * Shares gain 3.5 percent following setback for Novo nordisk’s rival
insulin Tresiba in U.S.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.